Agfa names leadership for combined businessesAgfa’s integration of Sterling Diagnostic Imaging has begun to move forward. The company has appointed its North American management team for the combined Sterling and Agfa businesses. Former
Agfas integration of Sterling Diagnostic Imaging has begun to move forward. The company has appointed its North American management team for the combined Sterling and Agfa businesses. Former Sterling employees are well represented.
Sterling COO Ernest Waaser has been named senior vice president of North America, replacing John Glass, who is now managing director of Agfas worldwide medical imaging business.
Sterling senior vice president for Americas Robert Pryor has been tapped as vice president of North American sales, handling field sales, national accounts, and the companys efforts in the U.S. militarys Digital Imaging Network-Picture Archiving and Communications Systems (DIN-PACS) project.
Agfa veteran Robert Cooke has been named vice president of Impax Solutions, continuing his previous responsibilities for product management, marketing, and professional services for the PACS and CR businesses. Michael Sullivan has been appointed vice president of customer support. He has handled similar responsibilities for Agfa.
Sterling executive director of worldwide marketing William Ward will head up marketing communications and strategy, while John Wilkens will lead the firms business development efforts. Wilkens had previously served as vice president of Sterlings Imaging Media Systems business.
Finally, Agfa has received a $5.6 million PACS and CR contract from Elmhurst Hospital Center in Elmhurst, NY. Agfa expects to complete installation at the 500-bed hospital in late September.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.